The next cohort of the highly regarded Life Sciences CEO Connection program will commence later this year at Procopio’s Palo Alto office, and a few slots are open for qualified participants. Including up to 25 early-stage life sciences CEOs, the program features monthly conversations thoughtfully curated by industry insiders. It fosters meaningful professional connections, advisory, and the support needed to address the unique challenges of leadership in the life sciences sector.

The Life Sciences CEO Connection program is a partnership between Procopio and CEO 360 Connect, founded by life sciences advisor and Cardiff Advisory Managing Partner David Crean. David will lead the program’s 12 monthly meetings, with discussion topics including capital financing, IP and licensing, mergers and acquisitions, talent management, growth strategies, and conflict resolution. Dynamic roundtable discussions allow for candid conversations in a confidential setting, with participants discussing their own challenges and benefiting from the collective wisdom and strategic insights of their peers.

Procopio Corporate Partner Paul Johnson, the leader of Procopio’s Emerging Company and Venture Capital practice, and Intellectual Property Partner Noel Gillespie will actively engage with participants.

“The enthusiasm and engagement in our monthly Life Science CEO Connection programs in Silicon Valley is energizing,” said Johnson. “It’s inspiring to see these innovative entrepreneurs engaging collaboratively to advance their companies and their careers.”

Nominations are now being accepted, and self-nominations are welcome. Qualified candidates will be CEOs of life sciences, medical device, and health tech companies, and will undergo a vetting process. Learn more and apply.